Skip to main content
Livermore
Livermore
ZHEN

ADC Therapeutics SA

ADCT
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0001771910

No open-market purchases or sales by ADC Therapeutics SA insiders were filed in the last 90 days; 113 institutions reported holding it in 13F filings for Q2 2026, worth $86.3M in total; no superinvestor holds it.

13F holders, Q1 2022

Institutional positions in ADC Therapeutics SA as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
49
−6 vs. Q4 2021
Shares held
34.1M
+324.7K (+1.0%) vs. Q4 2021
Total value
$501.3M
−$181.5M (−26.6%) vs. Q4 2021
New holders
4
17 more added
Sold out
10
11 more reduced

Compare with Q4 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ADCT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2022: 49 institutions
Q1 2021: 59 institutionsQ2 2021: 56 institutionsQ3 2021: 53 institutionsQ4 2021: 55 institutionsQ1 2022: 49 institutionsQ2 2022: 58 institutionsQ3 2022: 66 institutionsQ4 2022: 60 institutionsQ1 2023: 59 institutionsQ2 2023: 56 institutionsQ3 2023: 41 institutionsQ4 2023: 38 institutionsQ1 2024: 37 institutionsQ2 2024: 74 institutionsQ3 2024: 77 institutionsQ4 2024: 83 institutionsQ1 2025: 82 institutionsQ2 2025: 86 institutionsQ3 2025: 106 institutionsQ4 2025: 115 institutionsQ1 2026: 118 institutionsQ2 2026: 113 institutions
Value heldQ1 2022: $501.3M
Q1 2021: $801.3MQ2 2021: $816.3MQ3 2021: $890.6MQ4 2021: $682.8MQ1 2022: $501.3MQ2 2022: $274.1MQ3 2022: $176.5MQ4 2022: $149.1MQ1 2023: $90.9MQ2 2023: $97.5MQ3 2023: $35.4MQ4 2023: $56.4MQ1 2024: $155.8MQ2 2024: $163.7MQ3 2024: $172.9MQ4 2024: $112.4MQ1 2025: $77.3MQ2 2025: $182.1MQ3 2025: $271.3MQ4 2025: $292.8MQ1 2026: $312.9MQ2 2026: $86.3M
Institutions holding ADCT and their total value by quarter
QuarterHoldersValue
Q2 2026113$86.3M
Q1 2026118$312.9M
Q4 2025115$292.8M
Q3 2025106$271.3M
Q2 202586$182.1M
Q1 202582$77.3M
Q4 202483$112.4M
Q3 202477$172.9M
Q2 202474$163.7M
Q1 202437$155.8M
Q4 202338$56.4M
Q3 202341$35.4M
Q2 202356$97.5M
Q1 202359$90.9M
Q4 202260$149.1M
Q3 202266$176.5M
Q2 202258$274.1M
Q1 202249$501.3M
Q4 202155$682.8M
Q3 202153$890.6M
Q2 202156$816.3M
Q1 202159$801.3M

Institutions, Q1 2022

Shares, value and share of portfolio for each institution holding ADC Therapeutics SA; share changes are against Q4 2021.

Institutions holding ADCT in Q1 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Citigroup Inc33$00.00%+1+3.1%Added
Parallel Advisors, LLC10$00.00%00.0%Unchanged
Investors Research Corp20$00.00%00.0%Unchanged
Salem Investment Counselors Inc35$1.00K0.00%00.0%Unchanged
First Manhattan Co200$2.00K0.00%00.0%Unchanged
Assetmark, Inc165$2.00K0.00%+165New
Wells Fargo & Company200$3.00K0.00%00.0%Unchanged
Focused Wealth Management, Inc300$4.00K0.00%00.0%Unchanged
US Bancorp350$5.00K0.00%−150−30.0%Reduced
Tower Research Capital LLC (TRC)737$10.0K0.00%−1,452−66.3%Reduced
Royal Bank of Canada891$13.0K0.00%+412+86.0%Added
CWM, LLC950$14.0K0.00%00.0%Unchanged
Banque Cantonale Vaudoise1,000$15.0K0.00%00.0%Unchanged
Sterling Investment Advisors, Ltd.1,100$16.0K0.00%00.0%Unchanged
State of Wyoming2,882$42.0K0.02%+1,057+57.9%Added
Advisor Group Holdings, Inc.3,248$47.0K0.00%+3,011+1,270.5%Added
Prospera Financial Services Inc5,921$87.0K0.00%+5,921New
Bank of America Corp7,609$112.0K0.00%−93,268−92.5%Reduced
Cna Financial Corp15,515$228.0K0.07%+270+1.8%Added
Virtus ETF Advisers LLC19,193$282.0K0.13%00.0%Unchanged
Moneta Group Investment Advisors LLC19,469$286.0K0.01%−36−0.2%Reduced
Zurcher Kantonalbank (Zurich Cantonalbank)21,408$314.0K0.00%00.0%Unchanged
Rockefeller Capital Management L.P.24,971$365.0K0.00%00.0%Unchanged
Susquehanna Fundamental Investments, LLC28,949$425.0K0.01%−3,051−9.5%Reduced
Manufacturers Life Insurance Company, The64,402$951.9K0.00%+64,402New
Allianz Asset Management GmbH67,810$997.0K0.00%+9,780+16.9%Added
Ameriprise Financial Inc75,030$1.10M0.00%+8,678+13.1%Added
Alps Advisors Inc78,845$1.16M0.01%−9,944−11.2%Reduced
Morgan Stanley85,865$1.26M0.00%+15,022+21.2%Added
TD Asset Management Inc92,290$1.36M0.00%00.0%Unchanged
Indie Asset Partners, LLC96,572$1.42M1.07%−100.0%Reduced
Magnetar Financial LLC167,698$2.46M0.03%+40,000+31.3%Added
Walleye Capital LLC248,354$3.65M0.10%+202,876+446.1%Added
BlackRock Inc.304,229$4.47M0.00%+10,372+3.5%Added
Principal Financial Group Inc305,246$4.48M0.00%+2,012+0.7%Added
Employees Retirement System of Texas312,000$4.58M0.05%+34,000+12.2%Added
MPM Oncology Impact Management LP334,384$4.91M1.32%−3,012−0.9%Reduced
Matrix Capital Management Company, LP400,000$5.88M0.07%+400,000New
American Century Companies Inc421,297$6.19M0.00%+1230.0%Added
HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse)500,000$7.34M0.15%00.0%Unchanged
Pictet Asset Management SA1,295,018$19.0M0.02%−5,785−0.4%Reduced
Grosvenor Holdings, L.L.C.1,517,212$22.3M4.35%00.0%Unchanged
Vantage Consulting Group Inc1,680,149$24.7M9.63%00.0%Unchanged
Eventide Asset Management, LLC1,975,000$29.0M0.45%00.0%Unchanged
Price T Rowe Associates Inc2,462,636$36.2M0.00%−388,801−13.6%Reduced
Alliancebernstein L.P.2,957,056$43.4M0.02%+149,333+5.3%Added
JPMorgan Chase & Co3,414,630$50.2M0.01%+219,788+6.9%Added
Redmile Group, LLC7,432,429$109.2M3.41%−18,600−0.2%Reduced
FMR LLC7,681,046$112.8M0.01%+8,373+0.1%Added
Invesco Ltd.0$00.00%−242,643−100.0%Sold out
Millennium Management LLC0$00.00%−40,367−100.0%Sold out
Susquehanna International Group, LLP0$00.00%−25,866−100.0%Sold out
Caas Capital Management LP0$00.00%−12,958−100.0%Sold out
UBS Group AG0$00.00%−2,426−100.0%Sold out
Lazard Asset Management LLC0$00.00%−1,863−100.0%Sold out
Dark Forest Capital Management LP0$00.00%−387−100.0%Sold out
Group One Trading, L.P.0$00.00%−100−100.0%Sold out
Toth Financial Advisory Corp0$00.00%−70−100.0%Sold out
Simplex Trading, LLC0$00.00%−89−100.0%Sold out